Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126766921 | 12676692 | 1 | I | 20160729 | 20160810 | 20160823 | 20160823 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122203 | RANBAXY | 23.00 | YR | F | Y | 65.50000 | KG | 20160823 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126766921 | 12676692 | 1 | PS | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, UNK | 76990 | 20 | MG | ||||||||
126766921 | 12676692 | 2 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Unknown | 80 MG, UNK | U | U | 0 | 80 | MG | ||||||
126766921 | 12676692 | 3 | C | PHENYLEPHRINE HYDROCHLORIDE. | PHENYLEPHRINE HYDROCHLORIDE | 1 | Unknown | U | U | 0 | |||||||||
126766921 | 12676692 | 4 | C | LORATADINE. | LORATADINE | 1 | Unknown | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126766921 | 12676692 | 1 | Depression |
126766921 | 12676692 | 2 | Product used for unknown indication |
126766921 | 12676692 | 3 | Product used for unknown indication |
126766921 | 12676692 | 4 | Hypersensitivity |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126766921 | 12676692 | DS |
126766921 | 12676692 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126766921 | 12676692 | Constipation | |
126766921 | 12676692 | Decreased appetite | |
126766921 | 12676692 | Depressed mood | |
126766921 | 12676692 | Disturbance in attention | |
126766921 | 12676692 | Dizziness | |
126766921 | 12676692 | Dyspnoea | |
126766921 | 12676692 | Euphoric mood | |
126766921 | 12676692 | Fatigue | |
126766921 | 12676692 | Heart rate increased | |
126766921 | 12676692 | Hot flush | |
126766921 | 12676692 | Insomnia | |
126766921 | 12676692 | Malaise | |
126766921 | 12676692 | Nausea | |
126766921 | 12676692 | Palpitations | |
126766921 | 12676692 | Paraesthesia | |
126766921 | 12676692 | Psychiatric symptom | |
126766921 | 12676692 | Somnolence | |
126766921 | 12676692 | Suicidal ideation | |
126766921 | 12676692 | Thinking abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126766921 | 12676692 | 1 | 20160729 | 0 |